Bullous Pemphigoid

Common Name(s)

Bullous Pemphigoid

Bullous pemphigoid is a skin disorder characterized by large blisters. The blisters are usually located on the arms, legs, or middle of the body. About one-third of persons with bullous pemphigoid also develop blisters in the mouth. The blisters may break open and form ulcers or open sores. It usually occurs in elderly persons and is rare in young people. Symptoms come and go. In most patients, the condition goes away within 6 years. The cause is not known, but may be related to immune system disorders.
 

Advocacy and Support Organizations

 

Condition Specific Organizations

Following organizations serve the condition "Bullous Pemphigoid" for support, advocacy or research.

Logo
International Pemphigus and Pemphigoid Foundation

The IPPF provides direct access to innovative and effective support that promotes the very best health care, improves quality of life, stimulates community resources, advocates for favorable government policies, accelerates the pace of scientific discovery and is the world’s best source of information on pemphigus and pemphigoid. We are compassionate in understanding, tireless in service, and relentless in advocating. One person at a time, we make a difference, building a community of care and hope.

Last Updated: 8 Mar 2013

View Details

 

General Support Organizations

Not finding the support you need? Show General Support Organizations

 
 
Top

How do you compare to others with this condition?

Privately answer questions about your health. Let resources, you select, come to you.

Anonymously share and see how your answers compare with others with this condition while privately providing key pieces of information to medical researchers, disease advocacy groups, and others ONLY YOU select to help speed up cures and better alternatives.

 
 

Advocacy and Support Organizations

 

Condition Specific Organizations

Following organizations serve the condition "Bullous Pemphigoid" for support, advocacy or research.

Logo
International Pemphigus and Pemphigoid Foundation

The IPPF provides direct access to innovative and effective support that promotes the very best health care, improves quality of life, stimulates community resources, advocates for favorable government policies, accelerates the pace of scientific discovery and is the world’s best source of information on pemphigus and pemphigoid. We are compassionate in understanding, tireless in service, and relentless in advocating. One person at a time, we make a difference, building a community of care and hope.

http://www.pemphigus.org/

Last Updated: 8 Mar 2013

View Details

 

General Support Organizations

Not finding the support you need? Show General Support Organizations

 
 
 
 
Top

Scientific Literature

Articles from the PubMed Database

Research articles describe the outcome of a single study. They are the published results of original research.
The terms "Bullous Pemphigoid" returned 322 free, full-text research articles on human participants. First 3 results:

Bullous Pemphigoid: Validation of the National Patient Register in Two Counties in Sweden, 2001 to 2012.
 

Author(s): Carina Grönhagen, Karin Nilzén, Oliver Seifert, Kristofer Thorslund

Journal: Acta Derm. Venereol.. 2017 01;97(1):32-35.

 

Bullous pemphigoid (BP) is the most common autoimmune blistering disease. Since 2001, data from all specialized outpatient and inpatient care institutions in Sweden, have been registered with the National Patient Register (NPR), based on a unique personal identification number. Previous ...

Last Updated: 12 May 2016

Go To URL
A Potential Link between Amyotrophic Lateral Sclerosis and Bullous Pemphigoid: Six New Cases and a Systematic Review of the Literature.
 

Author(s): Shunya Nakane, Yuishin Izumi, Masaya Oda, Ryuji Kaji, Hidenori Matsuo

Journal: Intern. Med.. 2016 ;55(15):1985-90.

 

Objective Bullous pemphigoid in amyotrophic lateral sclerosis (BP-ALS) is rare and poorly understood. We herein assessed the association between ALS and BP using clinical and biological findings. Methods The clinical features of six new BP-ALS cases were described and collated with ...

Last Updated: 1 Aug 2016

Go To URL
Bullous pemphigoid successfully treated with omalizumab.
 

Author(s): Mü Zeyyen Gönül, Havva Ozge Keseroglu, Can Ergin, Ibrahim Özcan, Özlem Erdem

Journal: Indian J Dermatol Venereol Leprol. ;82(5):577-9.

 

Last Updated: 9 Aug 2016

Go To URL

Reviews from the PubMed Database

Review articles summarize what is currently known about a disease. They discuss research previously published by others.
The terms "Bullous Pemphigoid" returned 16 free, full-text review articles on human participants. First 3 results:

Three Cases of Bullous Pemphigoid Associated with Dipeptidyl Peptidase-4 Inhibitors - One due to Linagliptin.
 

Author(s): Francisco Manuel Ildefonso Mendonça, Francisco José Martín-Gutierrez, Juan José Ríos-Martín, Francisco Camacho-Martinez

Journal: Dermatology (Basel). 2016 ;232(2):249-53.

 

Bullous pemphigoid (BP) is an acquired subepidermal autoimmune blistering disease in which there are humoral and cellular responses against the BP180 and BP230 antigens. Dipeptidyl peptidase (DPP)-4 inhibitors enhance endogenous glucagon peptide-1 and glucose-dependent insulinotropic ...

Last Updated: 7 Apr 2016

Go To URL
Erythematous Variety of Bullous Pemphigoid: Case Report and Literature Review.
 

Author(s): Yukari Ise, Yasushi Suga, Kazuko Okumura, Osamu Negi, Norito Ishii, Takashi Hashimoto

Journal: Acta Derm. Venereol.. 2016 Mar;96(3):412-3.

 

Last Updated: 1 Mar 2016

Go To URL
Clinical and serological responses following plasmapheresis in bullous pemphigoid: two case reports and a review of the literature.
 

Author(s): Brian Chang, Ashok Tholpady, Richard S P Huang, Elena Nedelcu, Yu Bai

Journal: Blood Transfus. 2014 Apr;12(2):269-75.

 

Last Updated: 16 Jun 2014

Go To URL
 
 
Top

Symptoms, Diagnosis, and Treatment

There are currently no related results available in GeneReviews.

There are currently no related results available in Genetic Testing Registry.

 
 
Top

Clinical Trial Information This information is provided by ClinicalTrials.gov

Last Updated: 15 Jul 2016

Go to URL
Ixekizumab in the Treatment of Bullous Pemphigoid
 

Status: Not yet recruiting

Condition Summary: Bullous Pemphigoid; Pemphigoid

 

Last Updated: 4 Apr 2017

Go to URL
Genetic Susceptibility and Influence of the Microbiomae in Bullous Pemphigoid
 

Status: Recruiting

Condition Summary: Bullous Pemphigoid

 

Last Updated: 4 Oct 2016

Go to URL